Sartorius: 'Overproportionate' earnings growth led by US single-use uptake

By Dan Stanton

- Last updated on GMT

Sartorius: Significant double-digit growth led by US single-use uptake

Related tags Marketing

Gains in market share and better-than-expected market environment drove year-on-year sales growth of 36% for Sartorius’s bioprocessing business.

Sartorius published its nine-month 2015 figures today, and total sales across the group rose 29% on the same period last year to €830m ($943m).

But its Bioprocess Solutions sector, which comprises upstream and downstream biomanufacturing equipment and services, specialising in single-use systems, fared even stronger with sales up 36% to €605m and order intake up 39% to €637m.

The firm described these earnings as “overproportionate,”​ and CEO Joachim Kreuzburg attributed them “on the one hand to the excellent and better-than-expected market environment and, on the other hand, to our ongoing gains in market share.”

The firm also noted that all regions saw significant double-digit growth, but high-lighted the 55% year-on-year increase in the Americas region for the nine months, with the growth reaching 58% for the third quarter itself.

This supports a BCC Research report published in July​ suggesting the US will catch-up with - and overtake - Europe in implementing single-use technologies.

Related news

Show more

Related products

show more

Process optimization for mAb commercial manufacturing

Process optimization for mAb commercial manufacturing

Content provided by Catalent | 01-Jun-2023 | Product Presentation

Process characterization and validation is an important step in the product development journey and late-phase development, and it is required before transferring...

Related suppliers